Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMKBCS2)

Drug Name
PNU 101017 Drug Info
Synonyms U 101017
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMKBCS2

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting GABA(A) receptor gamma-3 (GABRG3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zolpidem DMWOSKJ Insomnia 7A00-7A0Z Approved [2]
Allopregnanolone DMNLHAC Depression 6A70-6A7Z approved [3]
Clobazam - Lundbeck DMW1OQ0 Anxiety disorder 6B00-6B0Z Approved [4]
Flumazenil DMPCG2L Benzodiazepine overdose PC91 Approved [2]
Stiripentol DMMSDOY Dravet syndrome 8A61.11 Approved [5]
Thiamylal DMHDF7B Anaesthesia 9A78.6 Approved [4]
Ganaxolone DMXJMKF Epileptic seizures 8A61-8A6Z Approved [3]
Mebutamate DM0KYI4 Anxiety disorder 6B00-6B0Z Approved [4]
Metharbital DM5A38V Epilepsy 8A60-8A68 Approved [4]
Etomidate DMZI3WO Anaesthesia 9A78.6 Approved [4]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GABA(A) receptor gamma-3 (GABRG3) TTEX6LM GBRG3_HUMAN Modulator [1]

References

1 Neuroprotective effects of the GABA(A) receptor partial agonist U-101017 in 3-acetylpyridine-treated rats. Neurosci Lett. 1997 May 30;228(1):45-9.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 415).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
5 Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels. Epilepsia. 2006 Apr;47(4):704-16.